Cargando…

The Proportion Cured of Patients with Resected Stage II–III Cutaneous Melanoma in Sweden

SIMPLE SUMMARY: Patients diagnosed with stage II–III cutaneous melanoma (CM) are at high risk of recurrences, but the CM-specific survival ranges from approximately 40–70%. Here, the cure proportions and survival among uncured stage II–III CM patients were estimated. The 1- and 5-year relative survi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eriksson, Hanna, Utjés, Deborah, Olofsson Bagge, Roger, Gillgren, Peter, Isaksson, Karolin, Lapins, Jan, Schultz, Inkeri Leonardsson, Lyth, Johan, Andersson, Therese M.-L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8158378/ https://www.ncbi.nlm.nih.gov/pubmed/34070092 http://dx.doi.org/10.3390/cancers13102456

Ejemplares similares

Trend Shifts in Age-Specific Incidence for In Situ and Invasive Cutaneous Melanoma in Sweden
por: Eriksson, Hanna, et al.
Publicado: (2021)

A Population-Based Comparison of the AJCC 7th and AJCC 8th Editions for Patients Diagnosed with Stage III Cutaneous Malignant Melanoma in Sweden
por: Isaksson, Karolin, et al.
Publicado: (2019)

Prognostic Significance of Sentinel Lymph Node Status in Thick Primary Melanomas (> 4 mm)
por: Holmberg, Carl-Jacob, et al.
Publicado: (2023)

Complications after surgery for malignant melanoma do not delay further treatment
por: Munkhammar, Sara, et al.
Publicado: (2021)

The Effect of Beta-Adrenergic Blocking Agents in Cutaneous Melanoma—A Nation-Wide Swedish Population-Based Retrospective Register Study
por: Katsarelias, Dimitrios, et al.
Publicado: (2020)

Survival after introduction of adjuvant treatment in stage III melanoma: a nationwide registry-based study
por: Helgadottir, Hildur, et al.
Publicado: (2023)

Health-related quality of life (FACT-GP) in Sweden
por: Lindqvist Bagge, Ann-Sophie, et al.
Publicado: (2020)

Reply to Comment on Katsarelias, D., et al. “The Effect of Beta-Adrenergic Blocking Agents in Cutaneous Melanoma—A Nation-Wide Swedish Population-Based Retrospective Register Study.” Cancers 2020, 12, 3228
por: Katsarelias, Dimitrios, et al.
Publicado: (2020)

Multiple Primary Melanoma Incidence Trends Over Five Decades: A Nationwide Population-Based Study
por: Helgadottir, Hildur, et al.
Publicado: (2020)

Tumor Burden and Health-Related Quality of Life in Patients with Melanoma In-Transit Metastases
por: Wesslau, Hanna, et al.
Publicado: (2022)

Challenges in modelling the proportion of undiagnosed HIV infections in Sweden
por: Andersson, Emmi, et al.
Publicado: (2019)

TRIM study protocol - a prospective randomized multicenter Trial to assess the Role of Imaging during follow-up after radical surgery of stage IIB-C and III cutaneous malignant Melanoma
por: Naeser, Ylva, et al.
Publicado: (2020)

Isolated Limb Perfusion With Melphalan Triggers Immune Activation in Melanoma Patients
por: Johansson, Junko, et al.
Publicado: (2018)

Effects of the Introduction of Modern Immunotherapy on the Outcome of Isolated Limb Perfusion for Melanoma In-Transit Metastases
por: Holmberg, Carl-Jacob, et al.
Publicado: (2023)

Microbiota of semen from stallions in Sweden identified by MALDI-TOF
por: Al-Kass, Ziyad, et al.
Publicado: (2020)

Meta-Analysis of Isolated Hepatic Perfusion and Percutaneous Hepatic Perfusion as a Treatment for Uveal Melanoma Liver Metastases
por: Bethlehem, Martijn S., et al.
Publicado: (2021)

Socio-economic class, rurality and risk of cutaneous melanoma by site and gender in Sweden
por: Pérez-Gómez, Beatriz, et al.
Publicado: (2008)

Surgery for gastrointestinal metastases of malignant melanoma — a retrospective exploratory study
por: Holmberg, Carl Jacob, et al.
Publicado: (2019)

Plasma proteome alterations by MAPK inhibitors in BRAF(V600)-mutated metastatic cutaneous melanoma()()
por: Babačić, Haris, et al.
Publicado: (2021)

Second primary cancers in patients with cutaneous malignant melanoma: a population-based study in Sweden.
por: Wassberg, C., et al.
Publicado: (1996)

The Effect of Temperature and Perfusion Time on Response, Toxicity, and Survival in Patients with In-transit Melanoma Metastases Treated with Isolated Limb Perfusion
por: Katsarelias, Dimitrios, et al.
Publicado: (2018)

Concomitant use of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study): protocol for a multicenter phase II open label study
por: Jespersen, Henrik, et al.
Publicado: (2019)

Childhood leukaemia: long-term excess mortality and the proportion ‘cured’
por: Shah, A, et al.
Publicado: (2008)

Bullous Pemphigoid-like Eruption Triggered by Targeted Therapy for Metastatic Melanoma
por: ERIKSSON, Hanna, et al.
Publicado: (2020)

Retrospective analysis of post-mortem findings in domestic ducks and geese from non-commercial flocks in Sweden, 2011–2020
por: Jansson, Désirée Seger, et al.
Publicado: (2021)

Amelanotic Melanoma Concealed by Psoriasis
por: CURMAN, Philip, et al.
Publicado: (2020)

Response and Toxicity of Repeated Isolated Limb Perfusion (re-ILP) for Patients With In-Transit Metastases of Malignant Melanoma
por: Belgrano, Valerio, et al.
Publicado: (2019)

Melanoma‐specific survival before and after inclusion in a familial melanoma dermatologic surveillance program in CDKN2A mutation carriers and non‐carriers
por: Pissa, Maria, et al.
Publicado: (2022)

Hemiarthroplasties after Hip Fractures in Norway and Sweden: A Collaboration between the Norwegian and Swedish National Registries
por: Gjertsen, Jan-Erik, et al.
Publicado: (2018)

Immunometabolic Network Interactions of the Kynurenine Pathway in Cutaneous Malignant Melanoma
por: Rad Pour, Soudabeh, et al.
Publicado: (2020)

Lead Time from First Suspicion of Malignant Melanoma in Primary Care to Diagnostic Excision: a Cohort Study Comparing Teledermatoscopy and Traditional Referral to a Dermatology Clinic at a Tertiary Hospital
por: Schultz, Karina, et al.
Publicado: (2023)

The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma
por: Ny, Lars, et al.
Publicado: (2021)

Design and implementation of RESCUR in Sweden for promoting resilience in children: a study protocol
por: Eriksson, Charli, et al.
Publicado: (2018)

Estimating the cure proportion of colorectal cancer and related factors after surgery in patients using parametric cure models
por: Izadi, Neda, et al.
Publicado: (2020)

Observations on the Cure of Cutaneous Diseases by Friction
por: Morison, Thomas
Publicado: (1820)

Cutaneous melanoma
por: Négrier, S, et al.
Publicado: (2001)

The Impact of Hyaluronan on Tumor Progression in Cutaneous Melanoma
por: Takabe, Piia, et al.
Publicado: (2022)

Electric scooter accidents leading to emergency department visits: influence of alcohol and outcomes in Stockholm, Sweden
por: Andersson, Olle, et al.
Publicado: (2023)

Extracellular microvesicle microRNAs as predictive biomarkers for targeted therapy in metastastic cutaneous malignant melanoma
por: Svedman, Fernanda Costa, et al.
Publicado: (2018)

Rhinovirus infections in western Sweden: a four-year molecular epidemiology study comparing local and globally appearing types
por: Sansone, M., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_4mi26e469u2acr3irfulm880tc